Pyrroloquinoline Quinone (PQQ) for Alzheimer's Disease
Also known as: PQQ, BioPQQ, Methoxatin
PQQ's mitochondrial biogenesis and NGF-stimulating effects address two core AD deficits — energy failure and neurotrophic decline.
Mechanism of Action
PQQ promotes new mitochondria formation through PGC-1α, stimulates NGF expression for cholinergic neuron support (similar to lion's mane), enhances synaptic plasticity via CREB activation, and provides potent antioxidant protection to hippocampal neurons.
General mechanism: Redox cycling cofactor. PGC-1α/CREB activator for mitochondrial biogenesis. NGF stimulator. Antioxidant (20,000+ redox cycles).
Current Evidence
Human studies show improved short-term memory and attention with PQQ supplementation. Synergy with CoQ10 demonstrated. Alzheimer's-specific trials needed.
Clinical Status: Phase I/II for cognitive enhancement. Available as supplement.
Safety Profile
Very safe. Present in foods (kiwi, parsley). Well-tolerated as supplement. No significant side effects.
Key Research Questions
- Does PQQ's NGF stimulation benefit AD cholinergic neurons?
- Can PQQ combined with CoQ10 address AD mitochondrial dysfunction?